Vistagen Therapeutics (VTGN) Current Deferred Revenue (2011 - 2026)
Vistagen Therapeutics' Current Deferred Revenue was $234,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 90.7% from $2.51 million a year earlier and down 86.3% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Current Deferred Revenue (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Current Deferred Revenue at Vistagen Therapeutics came in at $1.71 million, down 33.9% from FY2025.
- Current Deferred Revenue shows a five-year compound annual growth rate of 3.8% (FY2021 to FY2026).
- In earlier fiscal years, Current Deferred Revenue was $2.59 million in FY2025 (+227.2%), $791,000 in FY2024 (+10.8%), $714,000 in FY2023 (-42.6%) and $1.24 million in FY2022 (-12.4%).
- The fiscal Q1 2027 figure marks the lowest quarterly Current Deferred Revenue since fiscal Q4 2012.
- Compared with a year earlier, Current Deferred Revenue has declined for four straight quarters, with growth averaging 41.5% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was fiscal Q4 2025 (growth of 227.2%); the worst was fiscal Q1 2027 (a decline of 90.7%).
- Per Business Quant data, VTGN's Current Deferred Revenue in the three fiscal quarters before Q1 2027 was $1.71 million (Q4 2026), $2 million (Q3 2026) and $2.14 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Vistagen Therapeutics | 8.19 Mn | -207.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 234,000.00 |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.51 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 791,000.00 |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | 793,000.00 |
| Jun 30, 2023 | 714,300.00 |
| Mar 31, 2023 | 714,000.00 |
| Dec 31, 2022 | 712,300.00 |
| Sep 30, 2022 | 712,300.00 |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.42 Mn |
API Access
Vistagen Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();